One of the world's largest manufacturers of generic drugs.
AI-generated insights about Sandoz from various financial sources
Faces significant headwinds from potential tariffs and an unfavorable U.S. market structure, making it a high-risk investment highly leveraged to potential U.S. healthcare policy reform.
Faces significant headwinds from potential tariffs and an unfavorable U.S. market structure, making it a high-risk investment highly leveraged to potential U.S. healthcare policy reform.